Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Serotonin syndrome and rhabdomyolysis in venlafaxine poisoning: a case report.

Hanekamp BB, Zijlstra JG, Tulleken JE, Ligtenberg JJ, van der Werf TS, Hofstra LS.

Neth J Med. 2005 Sep;63(8):316-8.

2.

[Effects of venlafaxine extended release formulation on the clinical management of patients].

Carrasco JL, Díaz-Marsá M, López-Ibor JJ.

Actas Esp Psiquiatr. 2005 May-Jun;33(3):147-53. Review. Spanish.

PMID:
15918081
3.

Serotonin syndrome and the use of SSRIs.

Finfgeld DL.

J Psychosoc Nurs Ment Health Serv. 2004 Feb;42(2):16-20. Review.

PMID:
14982105
4.

Extended-release formulation of venlafaxine in the treatment of post-traumatic stress disorder.

Pae CU, Lim HK, Ajwani N, Lee C, Patkar AA.

Expert Rev Neurother. 2007 Jun;7(6):603-15. Review.

PMID:
17563244
5.

[Venlafaxine withdrawal syndrome: report of six cases and review of the literature].

Pinzani V, Giniès E, Robert L, Peyrière H, Abbar M, Blayac JP.

Rev Med Interne. 2000 Mar;21(3):282-4. Review. French.

PMID:
10763190
6.

[Serotonin syndrome: a potentially severe side effect of selective serotonin reuptake inhibitors].

Schlienger RG, Shear NH.

Dtsch Med Wochenschr. 1997 Nov 28;122(48):1495-9. Review. German. No abstract available.

PMID:
9441139
7.

[Venlafaxine and its discontinuation syndrome].

Sierra Santos L, Raigal Martín Y, Ortega García A, Barriochoa Martínez de Pisón C, Aparicio Jabalquinto G.

Aten Primaria. 1999 Dec;24(10):617-8. Review. Spanish. No abstract available.

PMID:
10659465
8.

Venlafaxine XR therapy for major depression and anxiety disorders. The clinical implications that its advantages pose.

Sussman N.

Postgrad Med. 1999 Nov;106(6 Suppl):31-6. doi: 10.3810/pgm.11.1999.suppl1.5. Review.

PMID:
19667502
9.

Antidepressants, old and new. A review of their adverse effects and toxicity in overdose.

Sarko J.

Emerg Med Clin North Am. 2000 Nov;18(4):637-54. Review.

PMID:
11130931
10.

Risk of serotonin syndrome with concomitant administration of linezolid and serotonin agonists.

Huang V, Gortney JS.

Pharmacotherapy. 2006 Dec;26(12):1784-93. Review.

PMID:
17125439
11.

[Applications and safety of modern antidepressants in patients with liver diseases].

Dubarek W, Kucia K.

Wiad Lek. 2007;60(1-2):28-33. Review. Polish.

PMID:
17607965
12.

Venlafaxine: a new class of antidepressant.

Hardy J, Argyropoulos S, Nutt DJ.

Hosp Med. 2002 Sep;63(9):549-52. Review.

PMID:
12357859
13.

Treatment of anxiety disorders with venlafaxine XR.

Thase ME.

Expert Rev Neurother. 2006 Mar;6(3):269-82. Review.

PMID:
16533131
14.

Maintenance therapy to prevent recurrence of depression: summary and implications of the PREVENT study.

Kornstein SG.

Expert Rev Neurother. 2008 May;8(5):737-42. doi: 10.1586/14737175.8.5.737. Review.

PMID:
18457530
15.

[Serotonin syndrome: report of a fatal case and review of the literature].

Bilbao Garay J, Mesa Plaza N, Castilla Castellano V, Dhimes Tejada P.

Rev Clin Esp. 2002 Apr;202(4):209-11. Review. Spanish.

PMID:
12003730
16.

Potential medical and surgical complications of serotonergic antidepressant medications.

Looper KJ.

Psychosomatics. 2007 Jan-Feb;48(1):1-9. Review.

PMID:
17209143
17.

Serotonin syndrome: a brief review.

Birmes P, Coppin D, Schmitt L, Lauque D.

CMAJ. 2003 May 27;168(11):1439-42. Review. No abstract available.

18.

Cardiovascular toxicity due to venlafaxine poisoning in adults: a review of 235 consecutive cases.

Howell C, Wilson AD, Waring WS.

Br J Clin Pharmacol. 2007 Aug;64(2):192-7. Epub 2007 Feb 12. Review.

19.

Venlafaxine and serious withdrawal symptoms: warning to drivers.

Campagne DM.

MedGenMed. 2005 Jul 6;7(3):22. Review.

20.

Simultaneous bilateral acute angle closure glaucoma following venlafaxine treatment.

Ezra DG, Storoni M, Whitefield LA.

Eye (Lond). 2006 Jan;20(1):128-9. Review. No abstract available.

PMID:
15746956

Supplemental Content

Support Center